No clinical study has shown that chewing nicotine gum causes cancer in humans. The largest and longest-running trial to directly test this question found that nicotine replacement therapy was not a significant predictor of lung cancer, gastrointestinal cancer, or cancer of any type, even after adjusting for smoking history. That said, the picture is more complicated than a simple “no.” Nicotine itself does things at the cellular level that make researchers uneasy, and a small number of gum users show unexpectedly elevated levels of a known carcinogen in their urine. Understanding where the reassurance comes from and where the lingering uncertainty lives is worth the time.
What the Biggest Clinical Trial Found
The most direct human evidence comes from an analysis embedded in the Lung Health Study, a large trial that followed thousands of smokers over years. Researchers looked at whether participants who used nicotine replacement therapy had higher cancer rates than those who did not. In statistical models adjusting for other risk factors, nicotine replacement therapy alone was not a significant predictor of lung cancer, while actual smoking during the study period was. When both variables were entered into the same model, smoking remained clearly significant and nicotine replacement therapy did not. The same held for gastrointestinal cancers and for all cancers combined.1PubMed Central. Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study
This is reassuring, but it has limits. The study was originally designed to look at lung function, not cancer. Most participants used nicotine replacement for months, not years, and follow-up periods may not capture cancers with long latency. Still, it remains the most cited piece of direct human evidence, and it found nothing alarming.
What Nicotine Gum Actually Contains
One reason nicotine gum is considered far safer than tobacco is what it does not contain. Tobacco smoke and chewing tobacco deliver thousands of chemicals, including polycyclic aromatic hydrocarbons and tobacco-specific nitrosamines, both well-established carcinogens. Nicotine gum delivers nicotine bound to a resin, along with sweeteners, flavoring, and pH-adjusting ingredients like sodium bicarbonate. When researchers measured levels of harmful and potentially harmful constituents in pharmaceutical nicotine replacement products, they found no quantifiable nitrosamines or polycyclic aromatic hydrocarbons, and the overall chemical profile was comparable to nicotine pouch products rather than smokeless tobacco.2PubMed Central. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs) An earlier analysis similarly found only trace amounts of tobacco-specific nitrosamines in nicotine replacement products, in contrast to the much higher levels in conventional tobacco.3PubMed. Tobacco-specific nitrosamines in new tobacco products
So the gum itself is essentially clean of the known cancer-causing chemicals in tobacco. The question that keeps researchers interested is whether nicotine on its own, stripped of all those other chemicals, can still cause problems.
How Nicotine Behaves in the Body’s Cells
Nicotine is not classified as a carcinogen in the traditional sense. It does not directly mutate DNA the way, say, benzene or certain nitrosamines do. But it is not biologically inert either. Lab studies have found that nicotine can damage DNA in human tissue samples, though these experiments use concentrations higher than what a person typically gets from chewing gum.
In one study using mini-organ cultures of human nasal tissue, exposure to nicotine at relatively high concentrations caused a dose-dependent increase in DNA damage, rising to more than five-fold above control levels at the highest dose tested.4PubMed. Genotoxicity of nicotine in mini-organ cultures of human upper aerodigestive tract epithelia A similar pattern was observed in human salivary gland cells, where significant DNA damage was detected at concentrations about ten-fold higher than peak nicotine levels measured in saliva after heavy smoking.5PubMed. Nicotine induces DNA damage in human salivary glands Work on human respiratory tract cells found that the damage could be completely blocked by an antioxidant and by a receptor blocker, suggesting that oxidative stress driven through nicotine’s own receptors is responsible rather than nicotine acting as a direct chemical mutagen.6PubMed. Analysis of nicotine-induced DNA damage in cells of the human respiratory tract
The consistent thread here is that nicotine at high enough concentrations can stress cells in ways that lead to DNA damage, but it does so through an indirect route. Whether the concentrations a gum user’s tissues actually experience are high enough to trigger the same effects in real life is an open question that lab-dish experiments cannot fully answer.
The Nitrosamine Problem
Here is where it gets genuinely interesting. Even though nicotine gum contains negligible amounts of nitrosamines when it leaves the factory, the body may produce small quantities of a specific carcinogen from nicotine itself. Nicotine gets metabolized into nornicotine, and nornicotine can react with nitrite in saliva to form N′-nitrosonornicotine, or NNN, a recognized carcinogen. Researchers demonstrated that simply incubating nornicotine with human saliva produced detectable NNN in eight out of ten samples, without adding any other chemical.7Nicotine & Tobacco Research. Nornicotine Nitrosation in Saliva and Its Relation to Endogenous Synthesis of N′-Nitrosonornicotine in Humans
This matters because it means the body can generate a tobacco-specific carcinogen from pure nicotine, regardless of the delivery method. A study measuring NNN levels in the urine of people using nicotine gum or lozenges found that roughly a third of users had NNN levels after quitting smoking that were comparable to, or even higher than, their baseline levels while still smoking.8PubMed Central. Presence of the carcinogen N′-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products That finding raised eyebrows, because the whole point of switching to NRT is to reduce carcinogen exposure.
To keep this in perspective, the overall carcinogen and toxicant burden for people who use only nicotine replacement is dramatically lower than for smokers. A cross-sectional study of long-term NRT users found that their levels of carcinogens and toxicants were markedly below those of cigarette smokers.9PubMed Central. Nicotine, carcinogen and toxicant exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study So even if some NNN is formed endogenously, the total exposure picture for gum users looks nothing like the exposure picture for someone who smokes.
Nicotine’s Influence on Tumor Growth and Blood Supply
Beyond DNA damage and nitrosamine formation, there is a third way nicotine could theoretically matter for cancer. Nicotine activates receptors on blood vessel cells, and through these receptors it can stimulate the growth of new blood vessels. Tumors depend on new blood-vessel growth to feed themselves and spread. Lab research has shown that nicotine accelerates this process, and that receptors on endothelial cells interact with growth factor signaling in ways that promote tumor-supporting blood supply.10PubMed Central. Nicotine and Pathological Angiogenesis11PubMed Central. Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor
Separately, nicotine has been shown to promote cell proliferation and to activate signaling pathways associated with tumor growth and spread, effects that are mediated through the same family of receptors found on many cell types throughout the body.12PubMed Central. Nicotinic acetylcholine receptor signaling in tumor growth and metastasis None of this means nicotine starts cancer. But it raises the concern that in someone who already has a tumor, nicotine could help that tumor grow faster or resist the body’s natural defenses. This distinction matters: promoting an existing cancer and causing a new one are different biological events, and the evidence for nicotine is much stronger on the promotion side.
Could Nicotine Gum Interfere with Cancer Treatment?
This is a practical question that does not get enough attention. Lab studies have found that nicotine can protect cancer cells from being killed by chemotherapy drugs. In lung cancer cells, nicotine blocked the cell-death process triggered by standard chemotherapy agents by activating a survival signaling pathway.13PubMed Central. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin A similar effect was observed in gastric cancer cells treated with cisplatin, where nicotine activated a survival pathway that countered the drug’s ability to kill tumor cells.14PLoS ONE. Nicotine Inhibits Cisplatin-Induced Apoptosis via Regulating α5-nAChR/AKT Signaling in Human Gastric Cancer Cells
These are laboratory findings, not clinical trials in patients. But they highlight a real concern for people undergoing cancer treatment who continue using nicotine gum. Most oncologists advise patients to discontinue all nicotine products during active treatment, and these studies help explain why. If you are being treated for cancer and still chewing nicotine gum, that conversation with your oncologist is worth having sooner rather than later.
Long-Term Gum Use and What It Means for Risk
Most people use nicotine gum for a few weeks or months while quitting smoking, but a substantial minority become long-term users. Research on this population found that the vast majority of people who chewed the gum for more than three months acknowledged they were addicted to it, and they showed clear signs of nicotine dependence.15PubMed. Dependence on the nicotine gum in former smokers Still, the same study noted that long-term use has no known serious adverse consequences and may be beneficial if it prevents a return to smoking.
From a cancer-risk standpoint, long-term use matters because it extends the period during which endogenous nitrosamine formation and nicotine’s pro-growth cellular effects are active. But it also extends the period during which the person is not smoking, which is an enormous net reduction in carcinogen exposure. The calculation is not close: continued gum use versus continued smoking is not a tradeoff where cancer risk is similar on both sides. Even in a worst-case reading of the nicotine-only research, the risk profile of gum use is vastly more favorable than the risk profile of cigarettes.
The Esophageal and Stomach Cancer Question
Because nicotine gum sits in the mouth and its juices are swallowed, people sometimes worry specifically about cancers of the mouth, esophagus, and stomach. A study that directly tested whether regular gum chewing was associated with esophageal or stomach-junction cancers found no increased risk. Regular users showed an odds ratio of 1.0 for esophageal adenocarcinoma and 1.0 for cardia adenocarcinoma, with no dose-response relationship based on duration of use.16European Journal of Cancer. Chewing gum and risk of oesophageal and gastric cardia adenocarcinoma That study looked at chewing gum broadly rather than nicotine gum specifically, but the absence of any signal even in regular, long-duration users is reassuring for the mechanical-exposure concern.
For pancreatic cancer, the picture is muddier. A review of the evidence noted that users of Swedish smokeless tobacco, which delivers nicotine along with other chemicals, have a slightly elevated risk of pancreatic cancer. But whether that elevation is due to nicotine or to the dozens of other carcinogenic compounds in smokeless tobacco remains unknown.17AACR Journals (Cancer Prevention Research). Long-term Nicotine Replacement Therapy: Cancer Risk in Context There is no comparable signal from pharmaceutical nicotine gum alone.
Nicotine Gum, the Oral Microbiome, and Inflammation
An area of growing interest is the effect of nicotine products on the community of bacteria in the mouth. A systematic review found that both smoked and smokeless tobacco shift the oral microbiome toward bacteria that thrive without oxygen, creating a more inflammatory environment.18Frontiers in Oral Health. Effect of different forms of tobacco on the oral microbiome in healthy adults: a systematic review Chronic inflammation in the mouth is linked to conditions ranging from gum disease to, in theory, an increased susceptibility to oral cancers over time. How much nicotine gum specifically alters the microbiome compared to tobacco products is not well characterized. It delivers nicotine to the same tissues, but without the tar, combustion byproducts, and the hundreds of other chemicals that are likely driving the biggest microbiome changes in smokers.
Metabolic Side Effects Worth Knowing About
Cancer is not the only long-term concern. A study published in Circulation found that prolonged use of nicotine gum was associated with higher insulin levels and greater insulin resistance, patterns that are also seen in smokers. The authors suggested that nicotine itself, rather than other components of cigarette smoke, is the primary driver of these metabolic changes, and recommended that nicotine replacement therapy be used transiently rather than indefinitely.19PubMed. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance Insulin resistance is relevant to cancer in a roundabout way, as it is associated with increased risk of several cancer types, though the connection from nicotine gum through insulin resistance to actual cancer is speculative and has not been demonstrated directly.
Pregnancy and Fetal Exposure
The question of cancer risk takes on different stakes during pregnancy. Nicotine crosses the placenta, and the body’s conversion of nicotine into carcinogenic nitrosamines does not stop just because the nicotine came from a patch or gum rather than a cigarette. A review of the evidence on fetal nicotine exposure noted that NNK, the nitrosamine formed from nicotine, is a transplacental carcinogen in animal models and that offspring of exposed animals develop tumors in multiple tissues. The authors cautioned that fetal exposure to nicotine from any source, including NRT, may increase the long-term risk of cancer in offspring, though more research is needed to confirm this in humans.20Toxicological Sciences. Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review – Section: Childhood Cancers This does not mean pregnant people should keep smoking instead; smoking delivers far more carcinogens than nicotine gum. But it does mean the decision to use nicotine gum during pregnancy should involve a frank conversation with a healthcare provider about the tradeoffs.
Where the Evidence Honestly Stands
The tension in this topic is between what happens in lab dishes and what shows up in human populations. In the lab, nicotine damages DNA at high concentrations, promotes blood-vessel growth that tumors exploit, protects cancer cells from chemotherapy drugs, and gets converted into a known carcinogen in human saliva. In real people, nicotine replacement therapy users do not show elevated cancer rates in the largest available trial, their carcinogen exposure is a small fraction of what smokers experience, and no epidemiological study has linked nicotine gum to increased cancer incidence.
Several explanations can coexist. The concentrations used in lab studies may be higher than what tissues experience in real life. The body’s repair mechanisms may handle the low-level DNA damage nicotine causes. The endogenous nitrosamine formation, while real, may produce too little carcinogen over too short a time to meaningfully raise risk. Or it may be that the risks are real but too small to detect without enormous studies and very long follow-up periods, particularly since most gum users chew for months rather than decades.
Researchers who have reviewed the full landscape have pointed out that nicotine’s role as an addictive substance may have distracted scientific attention from its other biological effects on cell growth, blood-vessel formation, and tumor behavior. That is a reasonable concern, but it is a call for more research rather than a conclusion that gum users are at meaningful cancer risk. For anyone choosing between continued smoking and nicotine gum, the comparison is not even close. For someone who has never smoked and is not using nicotine, there is no reason to start chewing nicotine gum, and the theoretical risks described here are one more reason among many.